Antimitotic drugs cause increased tumorigenicity of multidrug resistant cells.

Stuart L. Emanuel(Tris Pharma (United States)), Dalia Cohen(Regulus Therapeutics (United States)), H Chamberlin
International Journal of Oncology
March 1, 1999
Cited by 13


Related Papers